Dr Noam Shomron 370.
(photo credit:Tel Aviv University)
A Tel Aviv University team say they can diagnose the psychiatric disease of
schizophrenia at an early stage through the sense of smell instead of confirming
such a diagnosis only by examining the nerve cells in the brain after
The speedy and exact diagnosis using neurons taken from the
olfactory system was published recently in the medical journal Neurobiology of
A mental disorder characterized by a deficit of typical
emotional responses and a breakdown of thought processes, schizophrenia presents
symptoms that include paranoid or bizarre delusions, auditory hallucinations or
disorganized speech and thinking, along with social or occupational dysfunction.
These usually first appear in young adults.
schizophrenia based on observed behavior of the patient and his and family
members’ reported experiences. Neurobiology, genetics and early-life
environments are also believed to contribute to its development, but no single
organic cause has been discovered.
Recently, a TAU team headed by Dr.
Noam Shomron, Prof.
Ruth Navon and doctoral student Eyal Mor, in
cooperation with Dr. Akira Sawa, a Johns Hopkins University researcher in
Baltimore, developed a new technique for early physiological diagnosis of
They collected nasal tissue using a simple biopsy and
carried out a genetic analysis.
Shomron noted that the technique makes it
possible to diagnose the disease clearly and unequivocally at an early stage,
when schizophrenia treatment can be much more successful.
Shomron will lecture on the discovery at a schizophrenia conference in Orlando,
Florida. He explained that the team chose the olfactory sense because it is made
up of neurons found in the upper internal part of the nose. This makes it
possible to sample nerve cells without harming the individual.
collected such cells from known schizophrenics, along with similar cells from a
group of healthy people, and sent the cells to Shomron’s lab in Tel
Shomron’s team focused on a specific molecule of micro-RNA in the
cell that appears at high levels in schizophrenia patients and compared them
with the healthy individuals. Later, the team learned that the micro- RNA is
responsible for controlling genes connected to the production of
The new technique, Shomron said, is “very easy to carry out. The
biopsy is performed with a local anesthetic and no need for hospitalization, and
the results are ready in a few hours. We hope these results will form the basis
for developing an easy and exact technique to diagnose this serious and
The road to an absolutely positive diagnosis, he
continued, is still far away, but Shomron said he had much faith in the
The next step is to find out whether the change in the
expression of the micro-RNA molecule occurs before the schizophrenia symptoms or
only after the disease has developed.
“If it becomes clear that the
change occurs at an early stage and even before the disease breaks out, one can
use it for early diagnosis, which is impossible today. But it has great value,
because it can bring about early intervention and delay the appearance of
symptoms, thus preventing great suffering to the patient and his family,”
Thus, if a family has a known history of schizophrenia,
family members can undergo early diagnosis to find out if they are likely to
develop the disease.
Even though there is no complete cure, the future
patient and his doctors can prepare themselves for dealing with the challenges
that face them, the TAU researcher concluded.
Relevant to your professional network? Please share on Linkedin